From single-cell data to biological insights

Company Details

We are building a single-cell genomics platform that’s used in cancer and heart disease research. Our customers include Harvard Medical School, University of Glasgow and MD Anderson Cancer Centre.

Biomage Single Cell Platform turns your single cell datasets into meaningful biology. It’s free to get started, and you get world-class quality analytical insight: data integration, batch effect removal, beautiful publication-quality figures, and much more.

Researchers studying cancer, cardiovascular health, and developmental biology use our pipeline to make discoveries about complex biological systems. Your field could be next.

Company People

Adam Kurkiewicz

Adam Kurkiewicz

Iva Babukova

Iva Babukova

Marcell Pek

Marcell Pek


Please tell us a little bit about yourself and why you'd like to get connected.

Biomage + SOSV will follow up with you via email.

** If you are interested in investing directly into SOSV's portfolio of privately held companies, or into SOSV's funds, you need to meet the SEC’s criteria for accredited investor status. As an individual, you can qualify as an accredited investor by either (a) having more than $200,000 in annual income for each of the past two years (or $300,000 with your spouse) and a reasonable expectation of earning the same this year or (b) having a net worth of at least $1 million (not including your principal residence). Learn More

You might also be interested in

No Offer, Solicitation, Advice, or Recommendation

Except to the extent expressly set forth in materials as may be provided through a password protected area on the SOSV website (the "Materials"), or as otherwise expressly specified by SOSV in writing, nothing on the SOSV website or on any platform or other communications medium owned, operated or otherwise by or on behalf of SOSV, is intended to constitute (i) an offer, or solicitation of an offer, to purchase or sell any security, other asset or service, (ii) investment advice or an offer to provide such advice, or (iii) a basis for making any investment decision. Except as expressly stated by SOSV in writing, neither the SOSV website or any platform or other communications medium owned, operated or otherwise by or on behalf of SOSV, nor any of the Materials make any effort to present a comprehensive or balanced description of SOSV or its investment activities. Please note the SOSV Communication Policy available here.